Clinical Trial: Medication Development in Alcoholism: Investigating PPAR Agonists
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Medication Development in Alcoholism: Investigating PPAR Agonists
Brief Summary: The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
Detailed Summary:
Sponsor: The Scripps Research Institute
Current Primary Outcome: Craving to Drink [ Time Frame: 9 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Drinking Measured by Timeline Follow Back Interview [ Time Frame: 4 weeks ]
Original Secondary Outcome: Same as current
Information By: The Scripps Research Institute
Dates:
Date Received: May 28, 2014
Date Started: May 2014
Date Completion:
Last Updated: December 7, 2016
Last Verified: December 2016